Bone development is governed by growth hormone, thyroid hormone, insulin, and nutrition, mainly through the actions of the somatomedins.1 Recently we described three distinctly different phases of bone growth and mineralisation in normal children and adolescents.2 After a prepubertal phase of moderate growth velocity and little mineralisation the pubertal growth spurt, which coincided with a steep increase in serum testosterone in boys, indicated a short phase of grossly accelerated skeletal growth and mineralisation in both genders. During the following third phase linear growth took place at a low rate while intensive mineralisation continued.2 Thus, most of the minerals finally deposited in the skeleton traverse the blood stream during the last two phases of bone development. How Conversion: traditional to SI units-calcium: 1 mg/100 ml ;w 0.250 mmol/l; magnesium: 1 mg/100 ml w 0.411 mmol/l; phosphate: 1 mg/100 ml * 0.323 mmol/l. 19 and high concentrations of serum 1,25-dihydroxyvitamin D.5620 Serum iPTH is normal to slightly raised5 10-12 15 (Tables 1 and 2 ), but inappropriately high as judged from the level of serum calcium. The serum concentrations of growth hormone and somatomedins in children and adolescents are much lower than most of the values seen in acromegaly but differences in target organ sensitivities may account for the similarity of response.
Transport of minerals. An increased transport of minerals into the blood stream is also common to childhood, adolescence, and acromegaly. Both the intestinal absorption of calcium21 and the tubular reabsorption of phosphate915 are clearly raised. High levels of serum 1,25-dihydroxyvitamin D supposedly explain hyperabsorption of calcium and of phosphate22 from the gut. Its action on the renal transport of phosphate however, is disputable.
Hyperphosphataemia. Not surprisingly hyperphosphataemia is a prominent feature of childhood and adolescence7 12 (Tables 1 and 2 ) as of acromegaly.15 As hyperphosphataemia is bound to cause hypocalcaemia on its own, and only stimulates the secretion of parathyroid hormone through this mechanism,23 it is worth noticing that hypercalcaemia, relative or absolute, is characteristic of both conditions7 1012 15 21 (Tables 1 and 2 ). Accordingly, the serum Ca x P product is increased (Tables 1 and   2 ), thus creating favourable conditions for the mineralisation of bone matrix.
Hyperphosphatasia. Finally, childhood, adolescence, and acromegaly also have hyperphosphatasia7 812 24 and an increasing mineralised bone mass22425 in common.
Although growth hormone replacement therapy has failed to augment serum 1,25-dihydroxyvitamin D and iPTH in two small series of growth hormone-deficient children26 27 the bulk of evidence favours a hypothesis considering growth hormone as the primary driver and co-ordinator of mineral homeostasis and bone growth and mineralisation during childhood and adolescence. The main actions of growth hormone are outlined in Fig. 4 . By its several actions growth hormone is uniquely suited for adjusting mineral input, the Ca x P ion activity product, and bone matrix formation.
Rising levels of gonadal hormones, accelerated mineralisation of bone, and the growth spurt are intimately connected. 
